Form 4 for AGIO AGIOS PHARMACEUTICALS, INC.
Accepted 2023-08-11 00:00:00 ET · period of report 2023-08-09 · accession 0001439222-23-000125 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2023-08-11 | 2023-08-09 | AGIO | Foster-Cheek Kaye I | Dir | M - OptEx | $18.09 | +25.0K | 36.5K | +217% | +$452.2K |
| D | 2023-08-11 | 2023-08-09 | AGIO | Foster-Cheek Kaye I | Dir | S - Sale+OE | $25.96 | -25.0K | 11.5K | -68% | -$649.0K |
| D | 2023-08-11 | 2023-08-09 | AGIO | Foster-Cheek Kaye I | Dir | M - OptEx | $0.00 | -25.0K | 4,307 | -85% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common stock | 2023-08-09 | M | A | 25,000 | $18.09 | 36,524 | D | — | — | |
| 2 | Common | Common stock | 2023-08-09 | S | D | 25,000 | $25.96 | 11,524 | D | — | — | (F1) The price reported is the weighted average of the shares sold. The shares were sold at varying prices in the range of $25.69 to $26.37. The reporting person undertakes, upon request by the staff of the Securities and Exchange Commission, the issuer, or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price. |
| 3 | Derivative | Stock options (right to buy) | 2023-08-09 | M | D | 25,000 | $0.00 | 4,307 | D | $18.09 · — to 2032-06-21 | 25,000 Common stock | (F2) This option was granted on June 21, 2022. The shares underlying this option vest as to 100% of the underlying shares on June 21, 2023. |